Chorea-Acanthocytosis Presenting as Autosomal Recessive Epilepsy in a Family With a Novel VPS13A Mutation

Juliane Weber1, Lars Frings2, Michel Rijntjes1

  • 1Department of Neurology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.

Frontiers in Neurology
|January 29, 2019
PubMed

Insights

Chorea-acanthocytosis (ChAc) can present with epilepsy as the main symptom, challenging diagnosis. This study identifies a new VPS13A mutation in a family with seizures and basal ganglia involvement.

Area of Science:

  • Neurogenetics
  • Movement Disorders
  • Epileptology

Background:

  • Chorea-acanthocytosis (ChAc) is a rare autosomal recessive disorder typically presenting with movement abnormalities and acanthocytosis.
  • Mutations in the VPS13A gene are the known cause of ChAc.
  • This report details an unusual presentation within a consanguineous Turkish family.

Observation:

  • Three siblings presented with seizures, with one diagnosed with temporal lobe epilepsy.
  • Neuroimaging revealed basal ganglia involvement in the absence of overt movement disorders.
  • [18F]FDG-PET and [123I]FP-CIT-SPECT demonstrated reduced striatal glucose metabolism and dopamine transporter availability, respectively.

Findings:

  • Exome sequencing identified a novel homozygous VPS13A truncating mutation (c.4326 T>A, p.Tyr1442*) in affected siblings.
  • This mutation segregated with the epilepsy phenotype in the family.
  • Autosomal recessive epilepsy emerged as the predominant clinical manifestation.

Implications:

  • This case expands the phenotypic spectrum of Chorea-acanthocytosis, highlighting epilepsy as a potential primary presentation.
  • The findings underscore the importance of genetic testing for VPS13A in epilepsy cases with unexplained basal ganglia abnormalities.
  • This study contributes novel insights into the neurobiological underpinnings of ChAc and its variable clinical expressivity.